KORU Medical Systems (KRMD) Expected to Release Earnings on Wednesday

KORU Medical Systems (NASDAQ:KRMD) is expected to announce its Q2 2026 results after the market closes on Wednesday, August 5th. Analysts expect KORU Medical Systems to post earnings of ($0.02) per share and revenue of $11.6180 million for the quarter. Interested persons may visit the the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Wednesday, August 5, 2026 at 4:30 PM ET.

KORU Medical Systems Stock Performance

KRMD opened at $4.23 on Tuesday. KORU Medical Systems has a 52-week low of $3.20 and a 52-week high of $6.61. The firm has a market capitalization of $194.28 million, a PE ratio of -84.60 and a beta of 0.45. The business’s 50-day simple moving average is $4.13 and its 200 day simple moving average is $4.41.

Insider Transactions at KORU Medical Systems

In other KORU Medical Systems news, insider Adam R. Kalbermatten acquired 12,500 shares of the business’s stock in a transaction dated Thursday, June 11th. The stock was bought at an average cost of $3.94 per share, with a total value of $49,250.00. Following the completion of the transaction, the insider directly owned 312,500 shares in the company, valued at approximately $1,231,250. This represents a 4.17% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In the last three months, insiders have bought 28,000 shares of company stock valued at $109,430. Company insiders own 18.50% of the company’s stock.

Hedge Funds Weigh In On KORU Medical Systems

Hedge funds have recently bought and sold shares of the business. Cubist Systematic Strategies LLC grew its position in KORU Medical Systems by 927.4% during the first quarter. Cubist Systematic Strategies LLC now owns 77,280 shares of the company’s stock worth $196,000 after buying an additional 69,758 shares in the last quarter. Goldman Sachs Group Inc. lifted its position in shares of KORU Medical Systems by 189.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 242,781 shares of the company’s stock valued at $617,000 after acquiring an additional 158,914 shares during the period. Jane Street Group LLC grew its holdings in shares of KORU Medical Systems by 136.7% during the 1st quarter. Jane Street Group LLC now owns 163,137 shares of the company’s stock worth $414,000 after purchasing an additional 94,214 shares in the last quarter. Acadian Asset Management LLC acquired a new stake in shares of KORU Medical Systems during the 1st quarter worth $63,000. Finally, Geode Capital Management LLC increased its position in shares of KORU Medical Systems by 101.3% in the second quarter. Geode Capital Management LLC now owns 997,147 shares of the company’s stock worth $3,571,000 after purchasing an additional 501,875 shares during the period. 58.60% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research firms have weighed in on KRMD. Wall Street Zen upgraded KORU Medical Systems from a “hold” rating to a “buy” rating in a research note on Saturday, July 4th. Weiss Ratings raised KORU Medical Systems from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday. Four investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, KORU Medical Systems presently has an average rating of “Moderate Buy” and an average price target of $7.25.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products.